68H

SALBUTAMOL

Created: 2010-11-30
Last modified:  2011-06-04

Find related ligands:

Chemical Details

Formal Charge0
Atom Count38
Chiral Atom Count1
Bond Count38
Aromatic Bond Count6
2D diagram of 68H

Chemical Component Summary

NameSALBUTAMOL
Systematic Name (OpenEye OEToolkits)4-[(1R)-2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol
FormulaC13 H21 N O3
Molecular Weight239.311
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESCACTVS3.352CC(C)(C)NC[CH](O)c1ccc(O)c(CO)c1
SMILESOpenEye OEToolkits1.6.1CC(C)(C)NCC(c1ccc(c(c1)CO)O)O
Canonical SMILESCACTVS3.352 CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1
Canonical SMILESOpenEye OEToolkits1.6.1 CC(C)(C)NC[C@@H](c1ccc(c(c1)CO)O)O
InChIInChI1.03 InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3/t12-/m0/s1
InChIKeyInChI1.03 NDAUXUAQIAJITI-LBPRGKRZSA-N

Drug Info: DrugBank

DrugBank IDDB13139 
NameLevosalbutamol
Groups
  • approved
  • investigational
DescriptionLevosalbutamol, or levalbuterol, is a short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). [Salbutamol] has been marketed as a racemic mixture, although beta2-agonist activity resides almost exclusively in the (R)-enantiomer. The enantioselective disposition of salbutamol and the possibility that (S)-salbutamol has adverse effects have led to the development of an enantiomerically pure (R)-salbutamol formulation known as levosalbutamol (levalbuterol).
Synonyms
  • (-)-Salbutamol
  • R-salbutamol
  • (-)-Albuterol
  • Levosalbutamol tartrate
  • Levosalbutamol
Brand Names
  • Levalbuterol
  • Xopenex HFA
  • Levalbuterol Inhalation
  • Levalbuterol Hydrochloride
  • Levalbuterol Inhalation Solution
IndicationIndicated for the management of COPD (chronic obstructive pulmonary disease, also known as chronic obstructive lung disease) and asthma.
Categories
  • Adrenergic Agonists
  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Agonists
  • Agents producing tachycardia
  • Agents that produce hypertension
CAS number34391-04-3

Drug Targets

NameTarget SequencePharmacological ActionActions
Beta-2 adrenergic receptorMGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFG...unknownagonist
Solute carrier organic anion transporter family member 1B1MDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKS...unknownsubstrate
Solute carrier organic anion transporter family member 1B3MDQHQHLNKTAESASSEKKKTRRCNGFKMFLAALSFSYIAKALGGIIMKI...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL1002
PubChem 123600
ChEMBL CHEMBL1002
ChEBI CHEBI:8746
CCDC/CSD BHHPHE